Neurocrine Biosciences, Inc. Financial Ratios — NBIX Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	200.63
Return on Assets (%)	26.57	3.01	-26.29	-30.45	-24.78	-33.6	-24.1	2.33	3.22	26.79	4.71	6.96	8.89	9.79	11.46
Return on Capital (%)	-5.05	-0.7	- -	- -	- -	- -	- -	-6.26	-8.76	- -	-44.22	-94.15	396.8	113.84	71.04
Return on Invested Capital (%)	85.42	1.35	- -	- -	- -	- -	- -	5	18.02	- -	10.95	9.48	12.73	14.27	12.72
Gross Margin (%)	100	100	100	- -	100	100	99.22	98.91	99.06	99.03	98.74	98.44	97.9	98.56	98.18
EBITDA Margin (%)	44.72	3.96	-1,678.9	- -	-471.41	-972.79	-61.23	10.11	29.69	32.14	19.29	17.77	22.05	25.9	23.3
Operating Margin (%)	43.82	2.72	-1,701.88	- -	-476.51	-982.48	-62.71	9.22	28.75	31.31	18.33	16.73	20.92	24.75	22.25
Incremental Operating Margin (%)	108.5	133.79	- -	504.73	- -	- -	- -	49.37	54.91	39.14	-136.64	11.6	36.6	40.2	10.59
Pretax Margin (%)	48.53	9.46	-1,578.97	- -	-449.84	-940.6	-88.19	4.83	5.9	10.2	8.95	14.37	17.6	20.63	24.66
Profit Margin (%)	48.53	9.46	-1,578.97	- -	-449.84	-940.6	-88.19	4.68	4.69	38.94	7.9	10.38	13.23	14.49	16.73
Net Income to Common Margin (%)	48.53	9.46	-1,578.97	- -	-449.84	-940.6	-88.19	4.68	4.69	38.94	7.9	10.38	13.23	14.49	16.73
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	3.21	20.43	- -	11.64	27.77	24.81	29.77	32.15
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	200.63

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	- -	- -	- -	- -	370	388	496	412	440	263	428	455	415
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	409	- -	- -	169	170	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	370	388	87	412	440	94	258	455	415
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	-3.73	8.52	2.12	1.23	2.01	0.99	1.03	0.75	0.62
Net Debt/EBITDA	-1.45	-30.29	0.91	0.49	0.8	0.57	-1.16	5.41	1.27	0.39	-0.03	-0.35	-0.19	-0.38	-1.07
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	-3.65	9.34	2.19	1.26	2.12	1.06	1.09	0.78	0.65
Net Debt/EBIT	-1.48	-44.03	0.9	0.48	0.79	0.57	-1.13	5.93	1.31	0.4	-0.03	-0.38	-0.21	-0.4	-1.12
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	-5.07	1.5	7.31	10.25	8.48	37.27	90.46	4.82	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	-5.42	0.68	6.85	9.91	7.57	37.27	90.46	4.82	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	-5.19	1.36	7.08	9.98	8.05	35.07	85.83	4.61	- -
Interest Expense	- -	- -	- -	- -	- -	- -	20	30	32	33	26	7	5	127	- -
Common Equity/Total Assets	-523.71	-367.19	-495.03	-339.97	-192.75	-289.31	-146.62	-118.58	-86.72	-41.81	-30.67	-17.17	-4.83	0.79	9.67
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	99.32	80.81	13.61	36.61	32.05	5.47	11.57	17.57	12.77
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	-44.58	-49.23	-13.61	-131.73	-225.5	-65.02	95.17	93.95	48.12
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	45.21	39.12	6.64	23.77	21.25	3.95	7.94	12.24	8.97
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	99.32	80.81	77.8	36.61	32.05	15.39	19.19	17.57	12.77
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	-44.58	-49.23	-77.77	-131.73	-225.5	-182.82	157.85	93.95	48.12
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	45.21	39.12	37.94	23.77	21.25	11.1	13.18	12.24	8.97
Net Debt to Equity	-83.4	-41.3	-37.2	-14.86	-17.48	-26.44	30.88	51.33	46.55	11.61	-0.41	-5.47	-3.63	-9	-21.92
Net Debt/Capital (%)	6.47	8.14	5.53	3.62	7.5	7.31	-10.6	-26.51	-39.56	-26.15	1.06	22.99	-399.01	-92.68	-475.02
EBITDA	35	2	-49	-64	-93	-146	-99	46	234	336	219	265	416	610	667
EBITDA-CapEx	34	1	-50	-65	-95	-150	-106	21	219	325	195	265	416	610	667
Operating Income (Loss)	34	1	-50	-64	-94	-147	-101	42	227	328	208	249	395	583	636

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	2.74	11.06	12.46	12.37	14.75	10.11	9.48	7.38	1.19	4.29	2.89	1.84	1.58	2.12	1.99
Current Ratio	2.81	12.1	12.69	12.65	14.94	10.21	10.2	8.36	1.47	5.45	3.96	2.7	2.45	3.4	3.39
Quick Ratio	2.78	11.96	12.46	12.37	14.75	10.11	10.05	8.03	1.41	5.14	3.65	2.49	2.25	3.06	2.92
CFO/Avg Current Liab	-0.01	-1.12	-2.17	-3.45	-1.84	-3.78	-2.22	1.42	0.45	0.61	1.19	0.87	0.65	1.02	1.25
Common Equity/Total Assets	-523.71	-367.19	-495.03	-339.97	-192.75	-289.31	-146.62	-118.58	-86.72	-41.81	-30.67	-17.17	-4.83	0.79	9.67
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	99.32	80.81	13.61	36.61	32.05	5.47	11.57	17.57	12.77
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	-44.58	-49.23	-13.61	-131.73	-225.5	-65.02	95.17	93.95	48.12
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	45.21	39.12	6.64	23.77	21.25	3.95	7.94	12.24	8.97
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	99.32	80.81	77.8	36.61	32.05	15.39	19.19	17.57	12.77
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	-44.58	-49.23	-77.77	-131.73	-225.5	-182.82	157.85	93.95	48.12
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	45.21	39.12	37.94	23.77	21.25	11.1	13.18	12.24	8.97
CFO/Total Liabilities	-0.89	-84.83	-86.4	-137.3	-75.49	-211.48	-21.18	19.79	21.97	37.55	36.72	51.35	38.25	52.74	56.78
CFO/CapEx	-0.93	-36.35	-54.32	-29.24	-19.65	-25.85	-13.59	4.09	10	20.96	10.96	- -	- -	- -	- -
Altman's Z-Score	-1.63	3.3	4.04	24.38	54.58	35.68	7.68	7.26	9.04	10.01	7.79	11.61	8.86	8.85	7.81

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	10.38	10.19	8.57	7.37	6.62	5.56	4.78	5.13	4.91
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	35.15	35.81	42.61	49.5	55.16	65.65	76.33	71.16	74.38
Inventory Turnover	- -	- -	- -	- -	- -	- -	2.45	0.82	0.53	0.45	0.49	0.71	1.08	0.71	0.82
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	149.03	442.77	694.59	818.54	746.59	516.03	337.42	513.68	442.76
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	0.42	0.67	0.35	0.51	0.37	0.47	0.43	0.46	0.62
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	859.87	545.14	1,052.33	708.94	987.46	779.89	853.37	801.49	586.75
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	-675.69	-66.56	-315.13	159.1	-185.7	-198.21	-439.62	-216.64	-69.6
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	-113.88	-406.96	-651.97	-769.04	-691.43	-450.39	-261.09	-442.52	-368.38
Inventories	- -	- -	- -	- -	- -	- -	1	11	17	28	30	35	38	57	69
Raw Materials	- -	- -	- -	- -	- -	- -	- -	8	14	17	11	12	22	34	36
Work In Process	- -	- -	- -	- -	- -	- -	- -	2	2	2	4	6	10	11	19
Finished Goods	- -	- -	- -	- -	- -	- -	1	1	2	9	16	18	12	13	14
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	469	491	626	1,666	4,780	3,356	6,835	6,444	9,846	8,924	8,057	11,442	12,873	13,705	14,112
- Cash & Cash Equivalents	50	64	45	31	74	83	255	142	112	187	341	263	251	233	713
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	370	388	496	412	440	263	428	455	415
Enterprise Value	340	318	480	1,472	4,401	3,048	6,689	6,181	9,671	8,535	7,786	10,716	12,270	13,084	13,047
Total Capital	-725	-720	-766	-826	-915	-1,056	-829	-789	-637	-313	-195	-144	271	484	863
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	-44.58	-49.23	-77.77	-131.73	-225.5	-182.82	157.85	93.95	48.12
Total Debt / EV	- -	- -	- -	- -	- -	- -	0.06	0.06	0.05	0.05	0.06	0.02	0.03	0.03	0.03
EV/Sales	4.39	5.98	164.42	- -	222.61	203.23	41.38	13.7	12.27	8.16	6.87	7.2	6.5	5.55	4.56
EV/EBITDA	9.82	150.98	- -	- -	- -	- -	- -	135.55	41.33	25.39	35.6	40.5	29.49	21.45	19.57
EV/EBIT	10.02	219.49	- -	- -	- -	- -	- -	148.59	42.68	26.06	37.47	43.04	31.08	22.44	20.5
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	47.21	56.08	24.13	27.88	31.1	31.19	19.12	16.67
EV/Free Cash Flow to Firm	6,536.4	- -	- -	- -	- -	- -	- -	39.69	51.67	23.41	25.72	31.1	31.19	19.12	16.67
Diluted Market Cap	479	501	626	1,666	4,780	3,356	6,835	6,812	10,287	9,374	8,338	11,813	13,308	14,155	14,538
Diluted Enterprise Value	429	437	581	1,635	4,706	3,273	6,950	7,058	10,670	9,599	8,438	11,813	13,485	14,377	14,240
EV per Share	6.16	4.84	7.16	19.74	52.08	35.16	75.93	68.5	105.58	91.67	82.31	111.86	125.59	130.31	131.13
TTM Sales	77	53	3	- -	20	15	162	451	788	1,046	1,134	1,489	1,887	2,355	2,860
TTM EBITDA	35	2	-49	-64	-93	-146	-99	46	234	336	219	265	416	610	667
TTM Operating Income	34	1	-50	-64	-94	-147	-101	42	227	328	208	249	395	583	636
TTM Cash Flow to Firm	-1	-35	-30	-47	-38	-106	-75	131	172	354	279	345	393	684	783
TTM Free Cash Flow to Firm	- -	-34	-29	-46	-36	-102	-68	156	187	365	303	345	393	684	783

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	9,210.57	-14.59	-21.53	-36.59	-132.54	-32.88	-78.21	53.97	63.62	39.16	29.79	34.8	34.13	23.77	18.57
EV/EBIT	10.02	219.49	- -	- -	- -	- -	- -	148.59	42.68	26.06	37.47	43.04	31.08	22.44	20.5
Enterprise Value	340	318	480	1,472	4,401	3,048	6,689	6,181	9,671	8,535	7,786	10,716	12,270	13,084	13,047
Low Price	5.42	6.25	7.56	9.19	19.68	31.25	38.38	64.72	67.1	72.14	78.31	71.88	89.04	110.95	84.23
EV/Sales	4.39	5.98	164.42	- -	222.61	203.23	41.38	13.7	12.27	8.16	6.87	7.2	6.5	5.55	4.56
EV/EBITDA	9.82	150.98	- -	- -	- -	- -	- -	135.55	41.33	25.39	35.6	40.5	29.49	21.45	19.57
Price/Earnings	12.48	97.68	- -	- -	- -	- -	- -	305.39	266.11	21.91	89.92	74.06	51.55	40.15	29.49
Price/Earnings Average	10.37	100.87	-16.73	-20.05	-42.23	-27.82	-32.83	410	225.48	24.05	102.09	61.39	41.31	39.29	27.16
Price/Earnings High	12.85	130.32	-24.33	-30.62	-55.55	-34.38	-48.23	543.04	296.21	31.15	126.98	80.17	52.29	46.47	33.3
Price/Earnings Low	7.96	81.62	-10.99	-11.32	-18.7	-19.21	-23.72	276.78	166.12	16.49	82.68	44.57	34.84	32.64	17.51
Price/Book Value	-0.65	-0.68	-0.82	-2.02	-5.22	-3.18	-5.7	-5.47	-8.69	-12.3	-12.67	-28.13	-81.99	467.73	31.51
Price/Book Value Average	-0.54	-0.7	-1.01	-1.47	-4.1	-3.72	-3.9	-7.35	-7.37	-13.5	-14.39	-23.32	-65.7	457.7	29.02
Price/Book Value High	-0.67	-0.91	-1.46	-2.24	-5.4	-4.59	-5.74	-9.73	-9.68	-17.49	-17.9	-30.45	-83.16	541.34	35.59
Price/Book Value Low	-0.41	-0.57	-0.66	-0.83	-1.82	-2.57	-2.82	-4.96	-5.43	-9.26	-11.65	-16.93	-55.41	380.18	18.72
Price/Tangible Book Value	7.81	3.18	5.2	7.98	11.26	10.66	18.37	13.4	15.46	7.92	5.86	6.85	5.86	5.37	4.34
Price/Tangible Book Value Average	6.49	3.28	6.41	5.82	8.85	12.46	12.57	17.99	13.1	8.7	6.66	5.68	4.7	5.25	4
Price/Tangible Book Value High	8.04	4.24	9.31	8.88	11.64	15.41	18.48	23.83	17.21	11.26	8.28	7.41	5.94	6.21	4.9
Price/Tangible Book Value Low	4.98	2.66	4.21	3.28	3.92	8.61	9.08	12.15	9.65	5.96	5.39	4.12	3.96	4.36	2.58
Price/Sales	6.06	9.24	214.35	- -	241.79	223.72	42.29	14.28	12.49	8.53	7.11	7.69	6.82	5.82	4.93
Price/Sales Average	5.03	9.54	264.23	- -	189.95	261.66	28.95	19.17	10.59	9.36	8.07	6.37	5.47	5.69	4.54
Price/Sales High	6.24	12.32	384.17	- -	249.87	323.38	42.54	25.39	13.91	12.13	10.04	8.32	6.92	6.73	5.57
Price/Sales Low	3.86	7.72	173.5	- -	84.12	180.65	20.92	12.94	7.8	6.42	6.54	4.63	4.61	4.73	2.93
Price/Cash Flow	-671.91	-13.91	-21.13	-35.34	-125.8	-31.6	-72.46	63.55	66.98	39.05	31.41	33.71	33.02	23.02	18.03
Price/Cash Flow Average	-558.34	-14.36	-26.05	-25.75	-98.83	-36.96	-49.61	85.32	56.75	42.86	35.66	27.94	26.46	22.52	16.6
Price/Cash Flow High	-691.68	-18.55	-37.88	-39.33	-130	-45.68	-72.89	113	74.56	55.52	44.36	36.49	33.49	26.64	20.36
Price/Cash Flow Low	-428.44	-11.62	-17.11	-14.54	-43.76	-25.52	-35.84	57.59	41.81	29.39	28.88	20.29	22.31	18.71	10.71
Price/Free Cash Flow Average	7,653.76	-15.07	-26.54	-26.66	-104.13	-38.45	-53.55	72.46	53.9	42.97	33.82	28.85	27.35	23.26	17.11
Price/Free Cash Flow High	9,481.47	-19.47	-38.59	-40.72	-136.97	-47.52	-78.67	95.98	70.81	55.67	42.07	37.67	34.62	27.52	20.98
Price/Free Cash Flow Low	5,873.09	-12.19	-17.43	-15.05	-46.11	-26.55	-38.69	48.92	39.71	29.47	27.39	20.94	23.06	19.32	11.03
EV/Sales Average	4.39	8.34	248.89	- -	186.2	256.11	29.66	19.72	11.07	9.58	8.16	6.37	5.56	5.79	4.44
EV/Sales High	5.59	11.12	368.83	- -	246.11	317.83	43.25	25.94	14.39	12.34	10.13	8.32	7.01	6.83	5.47
EV/Sales Low	3.22	6.52	158.15	- -	80.36	175.1	21.63	13.49	8.29	6.64	6.62	4.63	4.7	4.82	2.83
EV/EBITDA Average	9.81	210.5	-14.82	-18.6	-39.5	-26.33	-48.45	195.13	37.29	29.81	42.28	35.84	25.22	22.35	19.05
EV/EBITDA High	12.5	280.82	-21.97	-28.67	-52.21	-32.67	-70.64	256.68	48.47	38.42	52.48	46.81	31.8	26.36	23.46
EV/EBITDA Low	7.19	164.54	-9.42	-10.29	-17.05	-18	-35.32	133.48	27.9	20.65	34.33	26.02	21.33	18.62	12.13
EV/EBIT Average	10.01	306.01	-14.62	-18.36	-39.08	-26.07	-47.3	213.89	38.51	30.59	44.5	38.09	26.58	23.38	19.95
EV/EBIT High	12.76	408.23	-21.67	-28.3	-51.65	-32.35	-68.96	281.37	50.06	39.42	55.23	49.74	33.52	27.59	24.57
EV/EBIT Low	7.34	239.2	-9.29	-10.16	-16.86	-17.82	-34.49	146.32	28.82	21.2	36.13	27.65	22.48	19.49	12.7
Last Price	8.5	7.48	9.34	22.34	56.57	38.7	77.59	71.41	107.49	95.85	85.17	119.44	131.76	136.5	141.83
High Price	8.75	9.98	16.74	24.86	58.46	55.94	78.05	126.98	119.65	136.26	120.27	129.29	133.64	157.98	160.18
Enterprise Value Average	340	443	727	1,183	3,681	3,842	4,794	8,898	8,726	10,019	9,247	9,484	10,493	13,633	12,699
Enterprise Value High	433	591	1,077	1,823	4,865	4,767	6,990	11,705	11,343	12,911	11,477	12,386	13,234	16,083	15,640
Enterprise Value Low	249	346	462	654	1,589	2,627	3,496	6,087	6,530	6,941	7,508	6,886	8,877	11,361	8,083

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	55	66	67	76	86	87	89	91	92	94	95	96	99	99	100
Diluted Weighted Avg Shares	56	67	67	75	84	87	88	95	96	98	98	99	101	104	102
Basic Weighted Avg Shares	55	66	67	75	84	87	88	90	92	93	95	96	98	100	100
Revenue per Share	1.4	0.81	0.04	- -	0.23	0.17	1.83	5	8.6	11.23	11.98	15.54	19.32	23.46	28.75
EBITDA per Share	0.63	0.03	-0.73	-0.85	-1.1	-1.68	-1.12	0.51	2.55	3.61	2.31	2.76	4.26	6.08	6.7
Operating Income per Share	0.61	0.02	-0.74	-0.86	-1.11	-1.7	-1.15	0.46	2.47	3.52	2.2	2.6	4.04	5.81	6.4
Basic EPS, GAAP	0.68	0.08	-0.69	-0.81	-1.05	-1.63	-1.62	0.23	0.4	4.37	0.95	1.61	2.56	3.4	4.81
Basic EPS from Cont Ops	0.68	0.08	-0.69	-0.81	-1.05	-1.63	-1.62	0.23	0.4	4.37	0.95	1.61	2.56	3.4	4.81
Diluted EPS, GAAP	0.67	0.08	-0.69	-0.81	-1.05	-1.63	-1.62	0.22	0.39	4.16	0.92	1.56	2.47	3.29	4.67
Diluted EPS from Cont Ops	0.67	0.08	-0.69	-0.81	-1.05	-1.63	-1.62	0.22	0.39	4.16	0.92	1.56	2.47	3.29	4.67
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.01	-0.54	-0.44	-0.63	-0.45	-1.22	-1.07	1.12	1.6	2.45	2.71	3.54	3.99	5.93	7.87
Free Cash Flow per Basic Share	-0.03	-0.55	-0.45	-0.65	-0.47	-1.27	-1.15	0.85	1.44	2.34	2.46	3.54	3.99	5.93	7.87
Cash & Equivalents per Share	2.34	2.64	2.18	2.6	4.49	3.54	5.86	7.21	7.32	8.6	7.52	10.33	10.56	10.72	14.88
Book Value per Share	-13.13	-10.97	-11.43	-11.08	-10.83	-12.18	-13.61	-13.05	-12.36	-7.79	-6.72	-4.25	-1.61	0.29	4.5
Tangible Book Value per Share	1.09	2.35	1.8	2.8	5.02	3.63	4.22	5.33	6.95	12.1	14.52	17.44	22.48	25.43	32.69

Neurocrine Biosciences, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)